|
Activities, Bill Numbers and Titles
|
|
|
|
Client: Novo Nordisk Inc.
|
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $4,825.00
|
|
House Bill
|
1999
|
An Act creating an obesity task force and pilot program
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1193
|
An Act providing for the establishment of a drug cost review commission
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
1289
|
An Act relative to diabetes prevention
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
4134
|
An Act to improve health care by investing in VALUE
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1852
|
An Act relative to diabetes prevention
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
2209
|
An Act to provide diabetes prevention program benefits
|
Support
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 05/12/2020 |
Dan Ryan
|
House, 2nd Suffolk
|
$100.00
|
| 05/12/2020 |
John Lawn
|
House, 10th Middlesex
|
$100.00
|
| 05/12/2020 |
Christine Barber
|
House, 34th Middlesex
|
$100.00
|
| | | Total contributions |
$300.00
|
|